Compare NKSH & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKSH | ARAY |
|---|---|---|
| Founded | 1891 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.1M | 31.3M |
| IPO Year | 1995 | 2006 |
| Metric | NKSH | ARAY |
|---|---|---|
| Price | $42.58 | $0.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 28.5K | ★ 414.5K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | ★ 100.81 | 87.50 |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $8,176,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.58 |
| P/E Ratio | $27.03 | ★ N/A |
| Revenue Growth | ★ 9.39 | N/A |
| 52 Week Low | $27.00 | $0.22 |
| 52 Week High | $43.31 | $2.10 |
| Indicator | NKSH | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 39.21 |
| Support Level | $34.90 | $0.23 |
| Resistance Level | $42.90 | $0.29 |
| Average True Range (ATR) | 0.98 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 86.55 | 16.38 |
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.